BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19322778)

  • 1. Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle.
    Hédou J; Bastide B; Page A; Michalski JC; Morelle W
    Proteomics; 2009 Apr; 9(8):2139-48. PubMed ID: 19322778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of O-GlcNAc sites on proteins.
    Whelan SA; Hart GW
    Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
    Graham ME; Thaysen-Andersen M; Bache N; Craft GE; Larsen MR; Packer NH; Robinson PJ
    J Proteome Res; 2011 Jun; 10(6):2725-33. PubMed ID: 21500857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-linked N-acetylglucosaminylation is involved in the Ca2+ activation properties of rat skeletal muscle.
    Hedou J; Cieniewski-Bernard C; Leroy Y; Michalski JC; Mounier Y; Bastide B
    J Biol Chem; 2007 Apr; 282(14):10360-9. PubMed ID: 17289664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry.
    Greis KD; Hayes BK; Comer FI; Kirk M; Barnes S; Lowary TL; Hart GW
    Anal Biochem; 1996 Feb; 234(1):38-49. PubMed ID: 8742080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
    Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
    Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
    Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
    Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc level variations are associated with the development of skeletal muscle atrophy.
    Cieniewski-Bernard C; Mounier Y; Michalski JC; Bastide B
    J Appl Physiol (1985); 2006 May; 100(5):1499-505. PubMed ID: 16357072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of O-GlcNAc glycosylation during Xenopus oocyte maturation.
    Lefebvre T; Baert F; Bodart JF; Flament S; Michalski JC; Vilain JP
    J Cell Biochem; 2004 Nov; 93(5):999-1010. PubMed ID: 15389870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of O-GlcNAc modification of cellular proteins in signal transduction].
    Krześlak A
    Postepy Biochem; 2007; 53(4):389-99. PubMed ID: 19024903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc modification: a nutritional sensor that modulates proteasome function.
    Zachara NE; Hart GW
    Trends Cell Biol; 2004 May; 14(5):218-21. PubMed ID: 15130576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.
    Hart GW; Housley MP; Slawson C
    Nature; 2007 Apr; 446(7139):1017-22. PubMed ID: 17460662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of O-linked N-acetylglucosamine proteins in rat skeletal muscle using two-dimensional gel electrophoresis and mass spectrometry.
    Cieniewski-Bernard C; Bastide B; Lefebvre T; Lemoine J; Mounier Y; Michalski JC
    Mol Cell Proteomics; 2004 Jun; 3(6):577-85. PubMed ID: 14985449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.
    Slawson C; Housley MP; Hart GW
    J Cell Biochem; 2006 Jan; 97(1):71-83. PubMed ID: 16237703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-translational modification by O-GlcNAc: another way to change protein function.
    Kudlow JE
    J Cell Biochem; 2006 Aug; 98(5):1062-75. PubMed ID: 16598783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.